Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Exchange: Toronto
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

AEterna Zentaris Inc

+ Add to Watchlist

AEZ:CN

2.1800 CAD 0.0900 4.31%

As of 15:46:55 ET on 05/17/2013.

Company Profile for AEterna Zentaris Inc (AEZ)

AEterna Zentaris Inc is a biopharmaceutical company focused in oncology and endocrine therapy. The Company's portfolio includes an orally-active inhibitor for multiple cancers, as well a product marketed for in vitro fertilization. AEterna Zentaris also develops and sells active ingredients, specialty chemicals, cosmetic, and nutritional products.

Contact Information

AEterna Zentaris Inc

1405 du Parc-Technologique Bvd
Quebec, PQ
Canada
Phone: 1-418-652-8525
Fax: 1-418-948-9191

Key Executives for AEterna Zentaris Inc (AEZ)

Juergen H L ErnstChairmanDavid A DoddPresident/CEO
Dennis TurpinSenior VP/CFOPaul BlakeSenior VP/Chief Medical Ofcr
Matthias SeeberSenior VP:Admin & Legal AffairsNicholas J PelliccioneSenior VP:Regulatory Affairs
Claude CardinalVP:Technical OperationsElliot ShapiroSecretary
Ginette Beaudet VallieresInvestor Relations Coordinator

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil